 Pergolide
"Pergolide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.
| Descriptor ID |
D010479
|
| MeSH Number(s) |
D03.132.327.287.800 D03.549.439.800
|
| Concept/Terms |
Pharken- Pharken
- Elanco Brand of Pergolide Mesylate
Permax- Permax
- Celance
- Parkotil
- Lilly Brand of Pergolide
- Lilly Brand of Pergolide Mesylate
- Athena Brand of Pergolide Mesylate
- Draxis Brand of Pergolide Mesylate
LY-127809- LY-127809
- LY127809
- LY-127,809
- LY127,809
|
Below are MeSH descriptors whose meaning is more general than "Pergolide".
Below are MeSH descriptors whose meaning is more specific than "Pergolide".
This graph shows the total number of publications written about "Pergolide" by people in this website by year, and whether "Pergolide" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 0 | 2 | 2 | | 1983 | 0 | 2 | 2 | | 1984 | 0 | 1 | 1 | | 1987 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pergolide" by people in Profiles.
-
Jandhyala BS, Lokhandwala MF, Kivlighn SD, Ansari AF, De Feo ML. Intracisternal administration of pergolide, a dopamine receptor agonist, triggers the release of an inhibitor of ouabain-sensitive sodium, potassium-dependent adenosine triphosphatase and enhances vascular reactivity in anaesthetized dogs. Clin Sci (Lond). 1987 Aug; 73(2):183-8.
-
Lokhandwala MF, Kivlighn SD, Jandhyala BS. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide. J Pharmacol Exp Ther. 1984 Mar; 228(3):696-703.
-
Barrett RJ, Lokhandwala MF. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs. Eur J Pharmacol. 1983 Dec 23; 96(3-4):211-26.
-
Jadhav AL, Willett RN, Sapru HN, Lokhandwala MF. Involvement of central dopamine receptors in the hypotensive action of pergolide. Naunyn Schmiedebergs Arch Pharmacol. 1983 Dec; 324(4):281-6.
-
Barrett RJ, Lokhandwala MF. Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide. Eur J Pharmacol. 1982 Jan 08; 77(1):79-83.
-
Barrett RJ, Lokhandwala MF. Presynaptic dopamine receptor stimulation and the antihypertensive action of pergolide in experimental neurogenic hypertension. Proc West Pharmacol Soc. 1982; 25:39-42.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|